Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Bayer HealthCare launches oncology treatment Xofigo in UK Bayer HealthCare has launched Xofigo (radium - 223 dichloride) solution for injection in the UK to treat adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

CordenPharma agrees to purchase Peptisyntha from Solvay
30 August 2013 | By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News
INVISTA, SilicoLife to develop new technologies for bio-derived processes
14 August 2013 | By PBR Staff Writer
INVISTA and SilicoLife, a computational biology company, have collaborated to develop new technologies that facilitate bio-derived processes for the production of industrial chemicals.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

Depomed announces settlements with two Gralise ANDA filers
15 April 2014
US-based specialty pharmaceutical company Depomed has announced it has entered into settlement agreements with two of the three defendants involved in the company's ongoing patent infringement litigation against filers of Abbreviated New Drug Applications (ANDAs) seeking approval to market generic versions of its Gralise (gabapentin) 300mg and 600mg tablets.
Production & Manufacturing > Process & Production > News
Advaxis announces notice of allowance for two patent applications in Japan
15 April 2014
Advaxis, a biotechnology company, has announced that the Japan Patent Office issued to the company two notices of allowance for two patent applications (P-72863-JP, P-7924) with claims for each patent application related to the company's proprietary cancer immunotherapy platform technology.
Production & Manufacturing > Process & Production > News

OTC

Prestige to acquire OTC oral rehydration product Hydralyte in Australia
16 April 2014 | By PBR Staff Writer
US-based Prestige Brands Holdings has signed an agreement to buy Hydralyte in Australia and New Zealand from The Hydration Pharmaceuticals Trust of Victoria, Australia.
Production & Manufacturing > OTC > News
Actavis announces agreement related to Generess FE patent challenge litigation
16 April 2014
Actavis has announced that it has entered into an agreement with Mylan and Famy Care to settle all outstanding patent litigation related to Mylan's generic version of Generess FE (norethindrone, ethinyl estradiol and ferrous fumarate chewable tablets).
Production & Manufacturing > OTC > News

Manufacturing

Sanofi launches Probi Digestis in Korea
16 April 2014
Swedish biotechnology company Probi has announced the signing of a distribution and supply agreement with Sanofi.
Production & Manufacturing > Manufacturing > News
PanOptica raises $45m to finance clinical development of anti-VEGF eye drop for wet AMD
16 April 2014
PanOptica has raised up to $45m in a Series B financing to fund the clinical program for its lead compound, PAN-90806, a pharmacologically unique small-molecule selective inhibitor of VEGF (vascular endothelial growth factor) signaling being investigated as a topical (eye drop) treatment for neovascular age-related macular degeneration (neovascular AMD).
Production & Manufacturing > Manufacturing > News